Wellness tools typically demand something most people cannot spare: time, attention, and ideal conditions. Audicin is building around that gap. The Finnish neurotech startup has raised $1.9 million (\u20ac1.6 million) to scale a system that passively regulates the nervous system in the background of everyday life, without asking users to pause anything.<\/p>\n
The round includes private investors and follow-on participation from Oura ring<\/a> co-founder\u00a0Petteri Lahtela<\/a>\u00a0and\u00a0Virpi Tuomivaara<\/a>, who also backed the company\u2019s earlier pre-seed. <\/p>\n Alongside the equity raise, Audicin has received support from\u00a0Business Finland<\/a>\u2018s selective Deep Tech Accelerator, a phased non-dilutive programme tied to technical and commercial milestones. Combined with previous rounds, total funding now stands at approximately $3 million.<\/p>\n The capital will accelerate the commercialisation of Audicin\u2019s app and Sleep Headband, and drive the rollout of Audicin for Apps: a lightweight SDK that allows digital health, performance, and consumer platforms to embed real-time nervous-system regulation directly into their user experiences, without requiring any new hardware.<\/p>\n Turning sound into a functional interface<\/p>\n Founded in 2022 by\u00a0Laura Avonius<\/a>\u00a0and Dr\u00a0Victoria Williamson<\/a>, Audicin grew out of Avonius\u2019 own recovery from complex PTSD. That experience exposed a fundamental design flaw in most wellness tools: they are built for ideal conditions, requiring time and calm that the people who need them most rarely have.<\/p>\n \u201cThe primary motivation was the feeling that most wellness and recovery tools were built for ideal conditions, not real life. I started Audicin during my own recovery from complex PTSD, and that period made it very clear to me how inadequate it is to ask people who are already overwhelmed, dysregulated, or exhausted to simply \u201ctake a moment\u201d and somehow fix themselves,\u201d Avonius tells TFN. <\/p>\n Avonius, also known as musician GEA, serves as CEO. Dr Williamson, a music psychologist and neuroscientist whose research focuses on how sound influences the brain and nervous system, leads research and product development as co-founder and Chief Scientist. <\/p>\n The company is supported by a Medical Advisory Board that includes Dr Hannu Kinnunen, former Chief Scientific Officer at Oura; Joel Naukkarinen, MD, an eight-time world champion; and Dr Jenni Hyysalo.<\/p>\n Audicin\u2019s platform combines brainwave entrainment, auditory engineering, and music neuroscience. It delivers sessions through psychoacoustic protocols that blend original compositions, precision-engineered binaural frequencies, and immersive spatial sound. Sessions are designed to run passively, triggered by biometric signals, time of day, or in-app events, without interrupting the user\u2019s activity.<\/p>\n